Search research articles
Contact Us
Filters
Showing results (631-640 of 792) with videos related to
Page
of 80
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 16, 2023
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, et al.
Lung Cancer (Auckland, N.Z.)
|
November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
Michael Thomas, David R Spigel, Robert M Jotte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 8, 2021
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study
Jonas Kuon, Miriam Blasi, Laura Unsöld, et al.
Trials
|
July 18, 2018
Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
Denise Bernhardt, Adriane Hommertgen, Daniela Schmitt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 24, 2025
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins
Michael Allgäuer, Klaus Kluck, Petros Christopoulos, et al.
The Lancet. Oncology
|
February 21, 2012
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Luis G Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Cancers
|
December 23, 2022
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts
Christos Chouaid, Michael Thomas, Didier Debieuvre, et al.
The American Journal of Clinical Nutrition
|
February 10, 2017
Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults
Sally M Vanegas, Mohsen Meydani, Junaidah B Barnett, et al.
Health Technology Assessment (Winchester, England)
|
March 1, 2021
Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study
Jonathan A Cook, Mathew Baldwin, Cushla Cooper, et al.
Page
of 80
Search research articles
Search
Showing results (631-640 of 792) with videos related to
Sort By:
Page
of 80
Lung Cancer (Amsterdam, Netherlands)
|
August 16, 2023
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, et al.
Lung Cancer (Auckland, N.Z.)
|
November 16, 2017
<i>nab</i>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
Michael Thomas, David R Spigel, Robert M Jotte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 8, 2021
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study
Jonas Kuon, Miriam Blasi, Laura Unsöld, et al.
Trials
|
July 18, 2018
Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
Denise Bernhardt, Adriane Hommertgen, Daniela Schmitt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 24, 2025
Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins
Michael Allgäuer, Klaus Kluck, Petros Christopoulos, et al.
The Lancet. Oncology
|
February 21, 2012
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Luis Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Luis G Paz-Ares, Filippo de Marinis, Mircea Dediu, et al.
Cancers
|
December 23, 2022
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts
Christos Chouaid, Michael Thomas, Didier Debieuvre, et al.
The American Journal of Clinical Nutrition
|
February 10, 2017
Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults
Sally M Vanegas, Mohsen Meydani, Junaidah B Barnett, et al.
Health Technology Assessment (Winchester, England)
|
March 1, 2021
Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study
Jonathan A Cook, Mathew Baldwin, Cushla Cooper, et al.
Page
of 80